congestive heart failure

Literature (6)

Literature for DOID 6000: congestive heart failure

Xenbase Articles Publications associated with this Disease Ontology entry or its descendants

:
(

Denotes literature images)

Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G)., Baroudi G,Pouliot V,Denjoy I,Guicheney P,Shrier A,Chahine M, Circ Res. June 22, 2001; 88(12):1524-4571.
Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure., Casey LM,Pistner AR,Belmonte SL,Migdalovich D,Stolpnik O,Nwakanma FE,Vorobiof G,Dunaevsky O,Matavel A,Lopes CM,Smrcka AV,Blaxall BC, Circ Res. August 20, 2010; 107(4):1524-4571.
Unexplained cardiac arrest: a tale of conflicting interpretations of KCNQ1 genetic test results., Chua HC,Servatius H,Asatryan B,Schaller A,Rieubland C,Noti F,Seiler J,Roten L,Baldinger SH,Tanner H,Fuhrer J,Haeberlin A,Lam A,Pless SA,Medeiros-Domingo A, Clin Res Cardiol. August 1, 2018; 107(8):1861-0692.
Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1., Wiedmann F,Schulte JS,Gomes B,Zafeiriou MP,Ratte A,Rathjens F,Fehrmann E,Scholz B,Voigt N,Müller FU,Thomas D,Katus HA,Schmidt C, Basic Res Cardiol. June 7, 2018; 113(4):1435-1803.
Contribution of Monocarboxylate Transporter 6 to the Pharmacokinetics and Pharmacodynamics of Bumetanide in Mice., Jones RS,Ruszaj D,Parker MD,Morris ME, Drug Metab Dispos. September 1, 2020; 48(9):1521-009X.
Loss-of-function variants in Kv 11.1 cardiac channels as a biomarker for SUDEP., Soh MS,Bagnall RD,Bennett MF,Bleakley LE,Mohamed Syazwan ES,Phillips AM,Chiam MDF,McKenzie CE,Hildebrand M,Crompton D,Bahlo M,Semsarian C,Scheffer IE,Berkovic SF,Reid CA, Ann Clin Transl Neurol. July 1, 2021; 8(7):2328-9503.

Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G)., Baroudi G,Pouliot V,Denjoy I,Guicheney P,Shrier A,Chahine M, Circ Res. June 22, 2001; 88(12):1524-4571.

Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure., Casey LM,Pistner AR,Belmonte SL,Migdalovich D,Stolpnik O,Nwakanma FE,Vorobiof G,Dunaevsky O,Matavel A,Lopes CM,Smrcka AV,Blaxall BC, Circ Res. August 20, 2010; 107(4):1524-4571.

Unexplained cardiac arrest: a tale of conflicting interpretations of KCNQ1 genetic test results., Chua HC,Servatius H,Asatryan B,Schaller A,Rieubland C,Noti F,Seiler J,Roten L,Baldinger SH,Tanner H,Fuhrer J,Haeberlin A,Lam A,Pless SA,Medeiros-Domingo A, Clin Res Cardiol. August 1, 2018; 107(8):1861-0692.

Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1., Wiedmann F,Schulte JS,Gomes B,Zafeiriou MP,Ratte A,Rathjens F,Fehrmann E,Scholz B,Voigt N,Müller FU,Thomas D,Katus HA,Schmidt C, Basic Res Cardiol. June 7, 2018; 113(4):1435-1803.

Contribution of Monocarboxylate Transporter 6 to the Pharmacokinetics and Pharmacodynamics of Bumetanide in Mice., Jones RS,Ruszaj D,Parker MD,Morris ME, Drug Metab Dispos. September 1, 2020; 48(9):1521-009X.

Loss-of-function variants in Kv 11.1 cardiac channels as a biomarker for SUDEP., Soh MS,Bagnall RD,Bennett MF,Bleakley LE,Mohamed Syazwan ES,Phillips AM,Chiam MDF,McKenzie CE,Hildebrand M,Crompton D,Bahlo M,Semsarian C,Scheffer IE,Berkovic SF,Reid CA, Ann Clin Transl Neurol. July 1, 2021; 8(7):2328-9503.